Skip to main content
Muller & Phipps (India) Ltd. logo

Muller & Phipps (India) Ltd. — Investor Relations & Filings

Ticker · 501477 ISIN · INE003F01015 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 248 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country IN India
Listing BSE.NS 501477

About Muller & Phipps (India) Ltd.

https://mulphico.swayantra.com/

Muller & Phipps (India) Ltd. focuses on the marketing and distribution of consumer healthcare, personal care, and home care products. The company manages a portfolio of established brands, including Sloan's Liniment and Nixoderm, specializing in over-the-counter pharmaceuticals and medicated skin care solutions. Its core operations involve managing complex supply chains and logistics networks to facilitate product placement across retail and pharmaceutical channels. The organization provides integrated brand management services, including sales strategy and distribution logistics, to ensure consistent market availability. By utilizing an extensive infrastructure and historical expertise in brand representation, the company serves as a key intermediary between manufacturing entities and the end-consumer market, maintaining a focus on quality and accessibility in its product range.

Recent filings

Filing Released Lang Actions
In terms of Clause 4 of the Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the exchange is hereby informed that the trading restriction ....
Regulatory Filings
2022-06-30 English
Dear Sir/ Madam In terms of SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019 we are submitting herewith the Annual Secretarial Compliance Report of the Company for the year ....
Regulatory Filings
2022-05-30 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed Public Notice published in ....
Earnings Release Classification · 90% confidence The document is a compliance notice under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, regarding the publication of audited financial results for the quarter and year ended March 31, 2022. It includes an extract of financial results (standalone and consolidated) for the quarter and year ended 31st March 2022. The document is about the announcement and publication of audited financial results, not the full detailed annual report itself. The length is about 15,000 characters, which is substantial, but the content is primarily a public notice and extract of financial results rather than a full annual report. Therefore, this is best classified as an Earnings Release (ER) since it announces quarterly and annual financial results highlights, not the full 10-K or Annual Report. It is not a report publication announcement (RPA) because it contains actual financial data (extracts).
2022-05-26 English
Pursuant to the Regulation 23(9) of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are submitting herewith the disclosure ....
Regulatory Filings
2022-05-25 English
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that the Board of Directors ....
Regulatory Filings
2022-05-24 English
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that the Board of Directors ....
Regulatory Filings
2022-05-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.